PRPH2 & Associated Retinal Diseases (PARD) Science Award

The PRPH2 & Associated Retinal Diseases (PARD) Science Award is co-funded by Nixon Visions Foundation and Foundation Fighting Blindness. It focuses on PRPH2 biology and retinal pathophysiology, with the goal of producing research that can point toward future treatments. Awards go up to USD 500,000 over one to three years. The current cycle uses a letter of intent followed by invitation-only full applications, and the program is narrowly scoped to PRPH2-related retinal disease rather than broader retinal biology. Nonprofit institutions, universities, and research organizations can apply; for-profit applicants are not eligible. The best fit is a project with a tight disease focus, a clear mechanistic question, and a credible translational edge. The FY26 cycle closed in 2025, and the next round is expected in 2026, so applicants should treat it as a specialized annual competition rather than a broad open call. The joint funding structure makes it a niche route for groups already aligned to PRPH2 biology, not a broad retinal-disease call.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.